Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin-resistant clinical isolates of staphylococci

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 1, 1998, Pages 100-107

  Sieradzki, Krzysztof ^a   Villari, Paolo ^a,b   Tomasz, Alexander ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; AUTOLYSIS; BACTERIUM CULTURE; BACTERIUM ISOLATION; CELL AGGREGATION; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; CULTURE MEDIUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 0031962757     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.1.100     Document Type: Article

References (26)

1. Aubert, G., S. Passot, F. Lucht, and G. Dorche. 1990. Selection of vancomycin- and teicoplanin-resistant Staphylococcus haemolyticus during teicoplanin treatment of Staphylococcus epidermidis infection. J. Antimicrob. Chemother. 25:491-493.
2. Biavasco, F., E. Giovanetti, M. P. Montanari, R. Lupidi, and P. E. Varaldo. 1991. Development of in-vitro resistance to glycopeptide antibiotics: assessment in staphylococci of different species. J. Antimicrob. Chemother. 27:71-79.
3. Billot-Klein, D., L. Gutmann, D. Bryant, D. Bell, J. van Heijenoort, J. Grewal, and D. M. Shlaes. 1996. Peptidoglycan synthesis and structure in Staphylococcus haemolyticus expressing increasing levels of resistance to glycopeptide antibiotics. J. Bacteriol. 178:4696-4703.
4. Centers for Disease Control. 1997. Staphylococcus aureus with reduced susceptibility to vancomycin - United States, 1997. Morbid. Mortal. Weekly Rep. 46:765-766.
5. Centers for Disease Control. 1997. Update: Staphylococcus aureus with reduced susceptibility to vancomycin - United States, 1998. Morbid. Mortal. Weekly Rep. 46:813-815.
6. Cooper, G. L., and D. B. Given. 1986. Vancomycin. A comprehensive review of 30 years of clinical experience. Lilly Research Laboratories, Indianapolis, Ind.
7. Daum, R. S., S. Gupta, R. Sabbagh, and W. M. Milewski. 1992. Characterization of Staphylococcus aureus isolates with decreased susceptibility to vancomycin and teicoplanin: isolation and purification of a constitutively produced protein associated with decreased susceptibility. J. Infect. Dis. 166:1066-1072.
8. De Jonge, B. L. M., H. de Lencastre, and A. Tomasz. 1991. Suppression of autolysis and cell wall turnover in heterogeneous Tn551 mutants of a methicillin-resistant Staphylococcus aureus strain. J. Bacteriol. 173:1105-1110.
9. De Lencastre, H., and A. Tomasz. 1994. Reassessment of the number of auxiliary genes essential for expression of high-level methicillin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 38:2590-2598.
10. Hiramatsu, K., H. Hanaki, T. Ino, K. Yabuta, T. Oguri, and F. C. Tenover. 1997. Methicillin resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J. Antimicrob. Chemother. 40:135-136.
11. Kaatz, G. W., S. M. Seo, N. J. Dorman, and S. A. Lerner. 1990. Emergence of teicoplanin resistance during therapy of Staphylococcus aureus endocarditis. J. Infect. Dis. 162:103-108.
12. +-linked D-lactate dehydrogenase associated with vancomycin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 40:166-172.
13. Moreira, B., S. Boyle-Vavra, B. L. M. de Jonge, and R. S. Daum. 1997. Increased production of penicillin-binding protein 2, increased detection of other penicillin-binding proteins, and decreased coagulase activity associated with glycopeptide resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 41:1788-1793.
14. National Committee for Clinical Laboratory Standards. 1993. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A3. National Committee for Clinical Laboratory Standards, Villanova, Pa.
15. Noble, W. C., Z. Virani, and R. G. A. Cree. 1992. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol. Lett. 93:195-198.
16. O'Hare, M. D., and P. E. Reynolds. 1992. Novel membrane proteins present in teicoplanin-resistant, vancomycin-sensitive, coagulase-negative Staphylococcus spp J. Antimicrob. Chemother. 30:753-768.
17. Sanyal, D., and D. Greenwood. 1993. An electron microscope study of glycopeptide antibiotic-resistant strains of Staphylococcus epidermidis. J. Med. Microbiol. 39:204-210.
18. Sanyal, D., A. P. Johnson, R. C. George, R. Edwards, and D. Greenwood. 1993. In-vitro characteristics of glycopeptide resistant strains of Staphylococcus epidermidis isolated from patients on CAPD. J. Antimicrob. Chemother. 32:267-278.
19. Schwalbe, R. S., W. J. Ritz, P. R. Verma, E. A. Barranco, and P. H. Gilligan. 1990. Selection for vancomycin resistance in clinical isolates of Staphylococcus haemolyticus. J. Infect. Dis. 161:45-51.
20. Shlaes, D. M., and J. H. Shlaes. 1995. Teicoplanin selects for Staphylococcus aureus that is resistant to vancomycin. Clin. Infect. Dis. 20:1071-1073.
21. Shlaes, D. M., J. H. Shlaes, S. Vincent, L. Etter, P. D. Fey, and R. V. Goering. 1993. Teicoplanin-resistant Staphylococcus aureus expresses a novel membrane protein and increases expression of penicillin-binding protein 2 complex. Antimicrob. Agents Chemother. 37:2432-2437.
22. Sieradzki, K., and A. Tomasz. 1997. Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus. J. Bacteriol. 179:2557-2566.
23. Sieradzki, K., and A. Tomasz. Unpublished data.
24. Tomasz, A., J. D. Jamieson, and E. Ottolenghi. 1964. The fine structure of Diplococcus pneumoniae. J. Cell Biol. 22:453-467.
25. Tomasz, A., S. Nachman, and H. Leaf. 1991. Stable classes of phenotypic expression in methicillin-resistant clinical isolates of staphylococci. Antimicrob. Agents Chemother. 35:124-129.
26. Woodford, N., A. P. Johnson, D. Morrison, and D. C. E. Speller. 1995. Current perspectives on glycopeptide resistance. Clin. Microbiol. Rev. 8:585-615.